MICHAEL PAYETTE: Open Payments
NPI 1952575573 · CROMWELL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851,482 in 954 payments from 25 companies in 2025. Trend: 2023 $631,199 · 2024 $848,240 · 2025 $851,482
Speaker / faculty: $610,285Consulting: $123,826Travel & lodging: $80,831Food & beverage: $19,685Honoraria: $16,800Education: $56
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 182 | $137,665 |
| ABBVIE INC. | 162 | $137,605 |
| Regeneron Healthcare Solutions, Inc. | 60 | $93,048 |
| Incyte Corporation | 74 | $78,632 |
| Lilly USA, LLC | 84 | $64,452 |
| Janssen Biotech, Inc. | 60 | $50,544 |
| PFIZER INC. | 43 | $49,966 |
| Galderma Laboratories, L.P. | 52 | $46,709 |
| GENZYME CORPORATION | 28 | $45,878 |
| Arcutis Biotherapeutics, Inc. | 39 | $41,402 |
Products named: Bimzelx, DUPIXENT, RINVOQ, Opzelura, EBGLYSS, TREMFYA, CIBINQO, NEMLUVIO.
Industry payments across CT — which companies pay providers there.
